Skip to Content

Haloperidol Lactate Injection

Last Updated: December 9, 2020
Status: Resolved

Products Affected - Description
    • Haloperidol lactate solution for injection, Fresenius Kabi, 5 mg/mL, 1 mL vial, 25 count, NDC 63323-0474-01
    • Haloperidol lactate solution for injection, Hikma, 5 mg/mL, 1 mL vial, 25 count, NDC 00143-9501-25
    • Haloperidol lactate solution for injection, Mylan Institutional, 5 mg/mL, 1 mL vial, 25 count, NDC 67457-0426-12
    • Haloperidol lactate solution for injection, Sagent, 5 mg/mL, 1 mL vial, 10 count, NDC 25021-0806-01
Reason for the Shortage
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional did not provide a reason for the shortage.
    • Sagent has haloperidol lactate on shortage due to manufacturing delays.
Available Products
    • Haldol solution for injection, Janssen, 5 mg/mL, 1 mL ampule, 10 count, NDC 50458-0255-01
    • Haloperidol lactate solution for injection, Fresenius Kabi, 5 mg/mL, 10 mL vial, 1 count, NDC 63323-0474-10
    • Haloperidol lactate solution for injection, Hikma, 5 mg/mL, 10 mL vial, 1 count, NDC 00143-9502-01
    • Haloperidol lactate solution for injection, Patriot Pharmaceuticals, 5 mg/mL, 1 mL ampule, 10 count, NDC 10147-0911-01

Estimated Resupply Dates

    • Fresenius Kabi has haloperidol lactate 5 mg/mL 1 mL vials on back order and the company estimates a release date of late-April 2019.
    • Hikma has haloperidol lactate 5 mg/mL 1 mL vials on allocation.
    • Mylan Institutional has haloperidol lactate 5 mg/mL 1 mL vials on back order and the company estimates a release date of mid-April 2019.
    • Sagent has haloperidol lactate 5 mg/mL 1 mL vials on back order and the company estimates a release date of May 2019.

Updated

Created December 9, 2020 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.